Bacterial Disease Diagnostics Market Share

  • Report ID: 5206
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Bacterial Disease Diagnostics Industry- Regional Synopsis

North American Market Forecast

 North America industry is predicted to dominate majority revenue share of 35% by 2037, due to rising instances of fatal infections caused by bacteria in the region. The growth of the market can be attributed majorly to the rising instances of fatal infections caused by bacteria in the region. The growing changes in the climatic conditions have led to its warming and have significantly increased the chances of bacterial infections. According to the latest research performed by the University of East Anglia (UEA) in the United Kingdom, the United States has become the hotspot of bacterial illness. The frequency of V. vulnificus infections in the United States has increased from 10 to 80 annually over 30 years.

APAC Market Statistics

The Asia Pacific bacterial disease diagnostics market is estimated to be the second largest, registering a share of about 28% by the end of 2037. The growth of the market can be attributed majorly to the rising cases of typhoid in the region. In the rainy season, the climate in India becomes extremely humid, owing to which, every year typhoid cases witness a jump of 30% in the monsoon. The cases are higher in rural regions but in 2023, the cases significantly increased in urban areas as well.

Bacterial Disease Diagnostics Market size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of bacterial disease diagnostics is assessed at USD 3.95 billion.

The bacterial disease diagnostics market size was valued at USD 3.49 billion in 2024 and is expected to reach USD 9.38 billion by 2037, registering around 7.9% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of bacterial infection and technological advancement in diagnostic technology will boost the market growth.

North America industry is predicted to dominate majority revenue share of 35% by 2037, due to rising instances of fatal infections caused by bacteria in the region.

The major players in the market are bioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, DiaSorin SpA (Luminex), Accelerate Diagnostics Inc., Bruker Corp., Danaher Corp., Torus Biosystems, GENERI BIOTECH s.r.o.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos